Baseline radiographic and microbiologic predictors of treatment outcomes in a shortened all-oral regimen for MDR/RR-TB
Abstract
WHO-endorsed shortened, all-oral regimens have improved tolerability and outcomes for MDR/RR-TB treatment, but predictors of poor outcomes remain incompletely-characterized. We conducted a prospective cohort study (NCT05871489) of adults with bacteriologically-confirmed pulmonary MDR/RR-TB treated with a shortened, all-oral regimen in Lesotho. We evaluated baseline microbiologic and radiographic features and their associations with time-to-culture-conversion, end-of-treatment outcomes, and final post-treatment outcomes. Among 238 participants (median age 41 [IQR:31–56], 29% female, 62% with HIV), there were 27 unfavorable outcomes (20 deaths, 3 treatment failures, 4 recurrences). 142 of 148 (95.9%) with positive baseline cultures experienced conversion within four months. Fibrosis, cavitation, bilateral disease, and high smear grade were associated with delayed culture conversion and lower odds of treatment success. Bilateral disease was more strongly associated with unfavorable outcomes in those without HIV; fibrosis and high smear grade showed stronger associations among those with HIV. Cavitation with high smear grade (uOR=0.29, 95%CI:0.11–0.78; aOR=0.39, 95%CI:0.14-1.14), and severe fibrocavitary disease (multi-lobar fibrosis and at least one cavity ≥5 cm) (uOR=0.20, 95%CI:0.07–0.64; aOR=0.26, 95%CI:0.07-0.94) were negatively associated with favorable final outcomes. These findings suggest that baseline sputum and chest radiographic features—particularly in-combination—identify higher-risk patients and may inform risk-adapted strategies for shortened all-oral MDR/RR-TB regimens.
Related
- Radiographic union rate and predictors of nonunion after primary surgical implant generation network intramedullary nailing for open tibial shaft fractures at a major trauma center in Ethiopia
- Shortened Obinutuzumab Infusion Is Safe and Reduces Chair Time in Frontline Treatment of Chronic Lymphocytic Leukemia: A Real-World Study.
- Long‐Term Clinical and Radiographic Outcomes of Large Periapical Lesions Managed by Non‐Surgical and Surgical Endodontic Treatment: A Case Series
- OphthoEvidence report: Baseline structural optical coherence tomography biomarkers as predictors of visual outcomes following full-thickness macular hole surgery: A systematic review and meta-analysis protocol
- A nomogram based on baseline predictors for Graves’ disease relapse after antithyroid drug withdrawal: a retrospective study
BibTeX
@article{shen2026baseline,
title = {{Baseline radiographic and microbiologic predictors of treatment outcomes in a shortened all-oral regimen for MDR/RR-TB}},
author = {Edmund Q. L. Shen and Stephane Mpinda and Llang Maama and Meseret Tamirat and Phate Sebakeng and Lawrence Oyewusi and Allison LaHood and Letizia Trevisi and Matthew Romo and Elna Osso and Michael L. Rich and Carole D. Mitnick and Kwonjune Justin Seung and Molly F. Franke and Kunda Kwabisha Mikanda},
journal = {Nature Communications},
year = {2026},
month = oct,
doi = {10.1038/s41467-026-78700-9},
url = {https://www.nature.com/articles/s41467-026-78700-9},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Baseline radiographic and microbiologic predictors of treatment outcomes in a shortened all-oral regimen for MDR/RR-TB
AU - Edmund Q. L. Shen
AU - Stephane Mpinda
AU - Llang Maama
AU - Meseret Tamirat
AU - Phate Sebakeng
AU - Lawrence Oyewusi
AU - Allison LaHood
AU - Letizia Trevisi
AU - Matthew Romo
AU - Elna Osso
AU - Michael L. Rich
AU - Carole D. Mitnick
AU - Kwonjune Justin Seung
AU - Molly F. Franke
AU - Kunda Kwabisha Mikanda
PY - 2026
DA - 2026/10/17
JO - Nature Communications
DO - 10.1038/s41467-026-78700-9
UR - https://www.nature.com/articles/s41467-026-78700-9
AB - WHO-endorsed shortened, all-oral regimens have improved tolerability and outcomes for MDR/RR-TB treatment, but predictors of poor outcomes remain incompletely-characterized. We conducted a prospective cohort study (NCT05871489) of adults with bacteriologically-confirmed pulmonary MDR/RR-TB treated with a shortened, all-oral regimen in Lesotho. We evaluated baseline microbiologic and radiographic features and their associations with time-to-culture-conversion, end-of-treatment outcomes, and final post-treatment outcomes. Among 238 participants (median age 41 [IQR:31–56], 29% female, 62% with HIV), there were 27 unfavorable outcomes (20 deaths, 3 treatment failures, 4 recurrences). 142 of 148 (95.9%) with positive baseline cultures experienced conversion within four months. Fibrosis, cavitation, bilateral disease, and high smear grade were associated with delayed culture conversion and lower odds of treatment success. Bilateral disease was more strongly associated with unfavorable outcomes in those without HIV; fibrosis and high smear grade showed stronger associations among those with HIV. Cavitation with high smear grade (uOR=0.29, 95%CI:0.11–0.78; aOR=0.39, 95%CI:0.14-1.14), and severe fibrocavitary disease (multi-lobar fibrosis and at least one cavity ≥5 cm) (uOR=0.20, 95%CI:0.07–0.64; aOR=0.26, 95%CI:0.07-0.94) were negatively associated with favorable final outcomes. These findings suggest that baseline sputum and chest radiographic features—particularly in-combination—identify higher-risk patients and may inform risk-adapted strategies for shortened all-oral MDR/RR-TB regimens.
SN - 2041-1723
ER -